[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="USA" width="100%" palette="financial-light"]

Food & Health

general-mills-reaffirms-guidance-after-recent-cut-amid-weak-1773848694014
General Mills Stands Firm Amid Demand Challenges
General Mills (GIS) reaffirmed its fiscal 2026 outlook Wednesday despite persistent pressure from consumer spending cuts and stiff competition hurting demand for Cheerios and other staples. The move signals management confidence in its brand investment strategy even as the packaged...
regenxbio-s-duchenne-gene-therapy-shows-muscle-function-gain-1773256857591
Regenxbio's Breakthrough in Duchenne Gene Therapy
Regenxbio Inc (RGNX.O) said Wednesday its experimental gene therapy for Duchenne muscular dystrophy showed...
Fresh $3 & $4 Deals at McDonald's: Value Menu Insights
McDonald’s Corp (MCD) plans to launch menu items priced at $3 or less starting in April, alongside $4 breakfast deals, as the fast-food giant...
Universal Health, Talkspace Join Forces in $835M Deal
Pfizer's Eczema Breakthrough: Tilrekimig Moves to Phase 3
GSK Transfers Liver Drug Rights to Alfasigma - TMT
J&J's Direct Drug Sales: A Bold Move Unveiled
GSK's Hepatitis B Drug Meets Primary Goals in Phase III Trials
fileName-Incyte-Blood-Cancer-Drug-Meets-Key-Trial-Goal-Shares-Rise-2
Incyte Blood Cancer Drug Meets Key Trial Goal, Shares Rise 2.3%
3 months ago
Incyte (INCY.O) shares jumped 2.3% Monday after its experimental blood cancer combination therapy met the primary goal in a late-stage trial. The positive trial results could accelerate...
fileName-Novo-Nordisk-Launches-Wegovy-Weight-Loss-Pill-at-149-Monthly-for-Self-Pay-Patients-1767621879883
Novo Nordisk Launches Wegovy Weight-Loss Pill at 149 Monthly for Self-Pay Patients
3 months ago
Novo Nordisk (NVO) launched its oral Wegovy weight-loss pill Sunday at 149 monthly for self-pay patients, marking the first GLP-1 obesity pill in the U.S. market. The launch positions...
fileName-Drugmakers-Raise-Prices-on-350-Medicines-Despite-Trump-Pressure-1767189753604
Drugmakers Raise Prices on 350 Medicines Despite Trump Pressure
3 months ago
Major pharmaceutical companies plan to raise U.S. prices on at least 350 branded medications in 2026 despite pressure from President Trump to lower drug costs 1. The price increases...
fileName-Ultragenyx-Shares-Plunge-After-Bone-Disease-Drug-Fails-Late-Stage-Trials-1767016930954
Ultragenyx Shares Plunge After Bone Disease Drug Fails Late-Stage Trials
3 months ago
Ultragenyx Pharmaceutical (RARE) shares tumbled after its experimental bone disease drug setrusumab failed to meet primary endpoints in two Phase 3 trials. The setback eliminates...
fileName-AstraZenecas-Lung-Cancer-Drug-Combo-Fails-Late-Stage-Trial-Shares-Drop-1-1766412424304
AstraZeneca's Lung Cancer Drug Combo Fails Late-Stage Trial, Shares Drop 1%
3 months ago
AstraZeneca (AZN.L) said Monday its ceralasertib-Imfinzi combination failed to improve survival in advanced lung cancer patients, sending shares down 1% as investors weighed the...
MORE NEWS
fileName-Krispy-Kreme-Sells-Japan-Operations-to-Unison-Capital-for-65-Million-1766163694832
Krispy Kreme Sells Japan Operations to Unison Capital for 65 Million
3 months ago
fileName-Trump-Set-to-Announce-Additional-Drug-Pricing-Deals-with-Pharmaceutical-Companies-1766163770602
Trump Set to Announce Additional Drug-Pricing Deals with Pharmaceutical Companies
3 months ago
fileName-roche-breast-cancer-drug-cuts-recurrence-risk-30-in-phase-iii-trial-1765375341869
Roche Breast Cancer Drug Cuts Recurrence Risk 30% in Phase III Trial
4 months ago
CATEGORIES